State Of Wyoming Global Blood Therapeutics, Inc. Transaction History

State Of Wyoming

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$22.3 - $37.39 $1,516 - $2,542	68 Added 31.78%	282 $9,000
Q1 2022 May 13, 2022	BUY	$25.68 - $35.59 $1,052 - $1,459	41 Added 23.7%	214 $7,000
Q4 2021 Feb 11, 2022	SELL	$24.9 - $40.26 $224 - $362	-9 Reduced 4.95%	173 $5,000
Q3 2021 Feb 11, 2022	SELL	$25.48 - $37.34 $2,242 - $3,285	-88 Reduced 32.59%	182 $5,000
Q2 2021 Feb 11, 2022	BUY	$32.46 - $43.42 $7,595 - $10,160	234 Added 650.0%	270 $9,000
Q1 2021 Feb 08, 2022	BUY	$38.94 - $50.85 $1,401 - $1,830	36 New	36 $1,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.